To require the Secretary of Health and Human Services to conduct a study on pharmacy benefit manager audit practices.

Bill 118 hr 10050, also known as the Pharmacy Benefit Manager Audit Practices Study Act, is a proposed piece of legislation that aims to address concerns surrounding the audit practices of pharmacy benefit managers (PBMs). PBMs are entities that manage prescription drug benefits on behalf of health insurers and employers.

The bill, if passed, would require the Secretary of Health and Human Services to conduct a study on the audit practices of PBMs. This study would aim to provide a comprehensive understanding of how PBMs conduct audits, including the frequency of audits, the criteria used for audits, and the impact of audits on pharmacies.

The study would also assess the potential impact of PBM audit practices on patient access to prescription medications, as well as the financial stability of pharmacies. Additionally, the bill would require the Secretary to submit a report to Congress detailing the findings of the study and any recommendations for potential legislative or regulatory action. Overall, the Pharmacy Benefit Manager Audit Practices Study Act seeks to shed light on the audit practices of PBMs and their potential impact on pharmacies and patients. By conducting a thorough study and providing recommendations for potential action, this bill aims to promote transparency and accountability within the PBM industry.